Citrobacter freundii

Cat no. YSL-qP-EC-C.freun-100

Citrobacter freundii

Cat no. YSL-qP-EC-C.freun-100

A complete qPCR kit for the detection of Citrobacter freundii

Citrobacter freundii is a common gram-negative bacterium known to cause healthcare-associated infections such as urinary tract infections, bloodstream infections, and pneumonia in humans. Early detection of Citrobacter freundii is crucial to prevent the spread of infections and the development of antibiotic resistance. Failure to detect this pathogen early can lead to severe illness and prolonged hospital stays, impacting both clinical outcomes and healthcare costs in the human health sector.

YouSeq's qPCR kit to detect Citrobacter freundii allows for sensitive and specific detection of this pathogen, enabling early intervention and treatment. By quickly identifying Citrobacter freundii, healthcare providers can implement appropriate infection control measures and select the most effective antibiotics, ultimately improving patient outcomes and reducing the risk of transmission in healthcare settings.

United States FlagAvailable for delivery in United States

Price on enquiry

Order now

For Research Use Only. Not intended for diagnostic use.

Contents


Target Specific primer/probe
Endogenous control primer/probe
qPCR OneStep MasterMix
Positive control template
DNase/RNase free water
Template resuspension buffer
ROX passive reference

Technical specification


Target Gene(s):WHTH domain containing protein
Efficiency: 90-110%
Sensitivity: <100 copy detection
Run Time: Approx 1hr30 (dependent on instrumentation)
Target Pathogen: FAM labelled
Endogenous Control: VIC/HEX labelled

Product variants


YSL-qP-EC-C.freun-100 : Lyophilised version for ambient shipping
YS-qP-EC-C.freun-100 : Frozen version for dry ice shipping

Pseudonyms

Citrobacter freundii; Citrobacter; Freundii; C. freundii; Coliform; Infections; UTI; Urinary tract infection; Bacteremia; Septicemia; Sepsis; Diarrhea; Enteric pathogen; Gram-negative bacteria; Healthcare-associated infections; HAIs; Hospital-acquired infections; Nosocomial infections

Related products

More products

Still scrolling? We love adventurers

We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.

More about us

Related learning resources